Year: 2024
Type: article
Study design: Case Report
Abstract: Juvenile myasthenia gravis is a rare disease in the paediatric age group caused by specific autoantibodies targeting proteins of the neuromuscular junction, with isolated ocular or generalized manifestations that improve with rest. The diagnosis is clinical, but it is confirmed by the presence of specific antibodies or abnormalities in nerve conduction. The management combines symptomatic treatment, immunosuppressants and, in some cases, thymectomy.
DOI: 10.60147/6d751d6e
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4405554818